Very high serum ferritin levels are associated with increased mortality and critical care in pediatric patients

Pediatric Critical Care Medicine

Volumn 12, Issue 6, 2011, Pages

  Bennett, Tellen D ^a   Hayward, Kristen N ^b   Farris, Reid W D ^b   Ringold, Sarah ^b   Wallace, Carol A ^b   Brogan, Thomas V ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

critical care; ferritin; hemophagocytic syndrome, reactive; lymphohistiocytosis, hemophagocytic; mortality

Indexed keywords

FERRITIN;

ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CHILD CARE; CHILDHOOD MORTALITY; CLINICAL FEATURE; FEMALE; FERRITIN BLOOD LEVEL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBINOPATHY; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; MALE; PRIORITY JOURNAL; RHEUMATIC DISEASE; SCHOOL CHILD; SURVIVAL RATE;

EID: 81155135069     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0b013e31820abca8     Document Type: Article

References (14)

1. Darveau M, Denault AY, Blais N, et al: Benchto-bedside review: Iron metabolism in critically ill patients. Crit Care 2004; 8:356-362
2. Jacobs BR, Lyons K, Brilli RJ: Erythropoietin therapy in children with bronchiolitis and anemia. Pediatr Crit Care Med 2003; 4:44-48
3. Allen CE, Yu X, Kozinetz CA, et al: Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2008; 50:1227-1235
4. Wood JC, Tyszka JM, Carson S, et al: Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. Blood 2004; 103:1934-1936
5. Chotsampancharoen T, Gan K, Kasow KA, et al: Iron overload in survivors of childhood leukemia after allogeneic hematopoietic stem cell transplantation. Pediatr Transplant 2009; 13:348-352
6. Garcia PC, Longhi F, Branco RG, et al: Ferritin levels in children with severe sepsis and septic shock. Acta Paediatr 2007; 96:1829-1831
7. Castillo L, Carcillo J: Secondary hemophagocytic lymphohistiocytosis and severe sepsis/systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. Pediatr Crit Care Med 2009; 10:387-392
8. Ravelli A, Magni-Manzoni S, Pistorio A, et al: Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr 2005; 146:598-604
9. Grom AA: Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: The same entities' Curr Opin Rheumatol 2003; 15:587-590
10. Janka GE: Hemophagocytic syndromes. Blood Rev 2007; 21:245-253
11. Henter JI, Horne A, Arico M, et al: HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48:124-131
12. Stephan J, Kone-Paut I, Galambrun C, et al: Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology (Oxford) 2001; 40:1285-1292
13. Sawhney S, Woo P, Murray KJ: Macrophage activation syndrome: A potentially fatal complication of rheumatic disorders. Arch Dis Child 2001; 85:421-426
14. Lacroix J, Hebert PC, Hutchison JS, et al: Transfusion strategies for patients in pediatric intensive care units. N Engl J Med 2007; 356:1609-1619